Imaging RNA modifications to understand cancer better
Fluorescence-based sequence-specific imaging of RNA modifications
This study is exploring new ways to see important changes in RNA that can affect diseases like acute myeloid leukemia, with the hope that it will lead to better tests and treatments for patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mediomics, LLC NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10822118 on NIH RePORTER |
What this research studies
This research focuses on developing new fluorescence-based methods to visualize specific RNA modifications that play crucial roles in various biological processes and diseases, including acute myeloid leukemia. By creating innovative imaging reagents, the project aims to enhance our understanding of how these RNA modifications affect cell behavior and contribute to cancer progression. Patients may benefit from improved diagnostic tools and targeted therapies as a result of this research. The project is currently in its early phases, working on establishing the feasibility of these novel imaging techniques.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with acute myeloid leukemia or other cancers linked to RNA modification disorders.
Not a fit: Patients with conditions unrelated to RNA modifications or those not diagnosed with cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic and therapeutic strategies for cancers like acute myeloid leukemia.
How similar studies have performed: While the approach of imaging RNA modifications is innovative, similar technologies have shown promise in other areas of cancer research, indicating potential for success.
Where this research is happening
Saint Louis, United States
- Mediomics, LLC — Saint Louis, United States (Active)
Researchers
- Principal investigator: Tian, Ling — Mediomics, LLC
- Study coordinator: Tian, Ling
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.